[go: up one dir, main page]

MXPA05010325A - Analisis proteomico de fluidos biologicos. - Google Patents

Analisis proteomico de fluidos biologicos.

Info

Publication number
MXPA05010325A
MXPA05010325A MXPA05010325A MXPA05010325A MXPA05010325A MX PA05010325 A MXPA05010325 A MX PA05010325A MX PA05010325 A MXPA05010325 A MX PA05010325A MX PA05010325 A MXPA05010325 A MX PA05010325A MX PA05010325 A MXPA05010325 A MX PA05010325A
Authority
MX
Mexico
Prior art keywords
fetal
biological fluids
conditions
maternal
proteome
Prior art date
Application number
MXPA05010325A
Other languages
English (en)
Inventor
Ron Rosenfeld
Original Assignee
Proteogenix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteogenix Inc filed Critical Proteogenix Inc
Publication of MXPA05010325A publication Critical patent/MXPA05010325A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Detergent Compositions (AREA)

Abstract

La invencion se refiere a la identificacion de proteomas de fluidos biologicos y su uso en la determinacion del estado de condiciones maternales/fetales, que incluye condiciones maternales de origen fetal, aneuploidias cromosomicas, y enfermedades fetales asociadas con crecimiento y maduracion fetal. En particular, la invencion se refiere a la identificacion del proteoma de fluido amniotico (multiples proteinas que representan la composicion de fluido amniotico) y la correlacion de los cambios caracteristicos en el proteoma normal con varias condiciones maternales/fetales patologicas, tal como infeccion intra-amniotica o defectos cromosomicos.
MXPA05010325A 2003-03-25 2004-03-23 Analisis proteomico de fluidos biologicos. MXPA05010325A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/400,005 US7191068B2 (en) 2003-03-25 2003-03-25 Proteomic analysis of biological fluids
PCT/US2004/008954 WO2004088324A2 (en) 2003-03-25 2004-03-23 Proteomic analysis of biological fluids

Publications (1)

Publication Number Publication Date
MXPA05010325A true MXPA05010325A (es) 2006-03-17

Family

ID=33096805

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05010325A MXPA05010325A (es) 2003-03-25 2004-03-23 Analisis proteomico de fluidos biologicos.

Country Status (12)

Country Link
US (3) US7191068B2 (es)
EP (2) EP1618388B1 (es)
JP (2) JP2006524331A (es)
CN (1) CN1795387A (es)
AT (1) ATE423322T1 (es)
AU (2) AU2004225527B2 (es)
CA (1) CA2560972A1 (es)
DE (1) DE602004019511D1 (es)
DK (1) DK1618388T3 (es)
ES (1) ES2322593T3 (es)
MX (1) MXPA05010325A (es)
WO (1) WO2004088324A2 (es)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060127962A1 (en) * 2002-11-14 2006-06-15 Ciphergen Biosystems, Inc. Biomarkers for intro-amniotic inflammation
US7191068B2 (en) * 2003-03-25 2007-03-13 Proteogenix, Inc. Proteomic analysis of biological fluids
US8068990B2 (en) * 2003-03-25 2011-11-29 Hologic, Inc. Diagnosis of intra-uterine infection by proteomic analysis of cervical-vaginal fluids
GB0313828D0 (en) 2003-06-16 2003-07-23 Owen Smith Brian D O Salivary urate for diagnosis of pre-eclampsia
CA2577587A1 (en) * 2003-08-21 2005-03-03 Mcgill University Method and apparatus for analyzing amniotic fluid
US20050233400A1 (en) * 2004-03-03 2005-10-20 Weiner Carl P Proteomic method for predicting success of rescue cerclage
WO2005093413A2 (en) * 2004-03-22 2005-10-06 Yale University Diagnosis and treatment of preeclampsia
JP2007536939A (ja) * 2004-05-14 2007-12-20 アモークス インコーポレーティッド 免疫細胞バイオセンサーおよびその使用方法
US9487575B2 (en) 2004-07-14 2016-11-08 The Regents Of The University Of California Compositions and methods for treatment of gynecologic cancers
US9488655B2 (en) * 2004-07-14 2016-11-08 The Regents Of The University Of California Biomarkers for detection of early- and late-stage endometrial cancer
US7670792B2 (en) * 2004-07-14 2010-03-02 The Regents Of The University Of California Biomarkers for early detection of ovarian cancer
EP2199801B1 (en) 2004-07-14 2013-05-29 The Regents of The University of California Biomarkers for early detection of ovarian cancer
WO2006034427A2 (en) * 2004-09-20 2006-03-30 Proteogenix, Inc. Diagnosis of fetal aneuploidy
KR20070092737A (ko) * 2004-12-15 2007-09-13 베스 이스라엘 데코니스 메디칼 센터 임신 합병증의 진단 및 치료에 유용한 핵산 및 폴리펩티드
WO2006081473A2 (en) 2005-01-28 2006-08-03 Children's Medical Center Corporation Methods for diagnosis and prognosis of epithelial cancers
WO2006097049A1 (en) * 2005-03-18 2006-09-21 The Chinese University Of Hong Kong A method for the detection of chromosomal aneuploidies
EP1869463A4 (en) 2005-04-15 2010-05-05 Becton Dickinson Co SEPSIS DIAGNOSIS
US20070087387A1 (en) * 2005-04-21 2007-04-19 Prasad Devarajan Method for the Early Detection of Renal Disease Using Proteomics
CA2621953A1 (en) * 2005-09-09 2007-03-22 University Of Iowa Research Foundation Biomarkers associated with age-related macular degeneration
US7312079B1 (en) 2005-10-06 2007-12-25 Lexicon Pharmaceuticals, Inc. Variants of FAM3C
US20070190580A1 (en) * 2005-10-31 2007-08-16 Beckman Coulter, Inc. Immunoassay of Fragments of Insulin-Like Growth Factor Binding Proteins
US20070162992A1 (en) * 2006-01-09 2007-07-12 Mcgill University Metabolomic determination in assisted reproductive technology
US20090215085A1 (en) * 2006-01-27 2009-08-27 Eastern Virginia Medical School Proteomic Fingerprinting of Human IVF-Derived Embryos: Identification of Biomarkers of Developmental Potential
US7790463B2 (en) 2006-02-02 2010-09-07 Yale University Methods of determining whether a pregnant woman is at risk of developing preeclampsia
US20090305259A1 (en) * 2006-03-21 2009-12-10 Yale University Early Diagnosis of Congenital Abnormalities in the Offspring of Diabetic Mothers
ES2418434T3 (es) * 2006-08-16 2013-08-13 National Research Council Of Canada Inhibición de la angiogénesis, de la tumorigénesis y de la actividad de la catepsina usando una proteína de unión al factor de crecimiento similar a la insulina
US20100137263A1 (en) * 2006-10-20 2010-06-03 Newcastle Innovation Limited Assay for the detection of biomarkers associated with pregnancy related conditions
AU2007338634A1 (en) * 2006-12-26 2008-07-03 Brigham Young University Serum proteomics system and associated methods
WO2008112424A1 (en) * 2007-03-08 2008-09-18 Mayo Foundation For Medical Education And Research Assessing heart failure
US20100113286A1 (en) * 2007-05-05 2010-05-06 Gilles Andre Lajoie Methods for detection of preeclampsia
GB0711327D0 (en) 2007-06-12 2007-07-25 Hansa Medical Ab Diagnostic method
FR2919065B1 (fr) 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage de l'apolipoproteine ai pour le diagnostic in vitro du cancer colorectal
FR2919060B1 (fr) 2007-07-19 2012-11-30 Biomerieux Sa Procede de dosage de l'ezrine pour le diagnostic in vitro du cancer colorectal.
JP5715817B2 (ja) 2007-07-19 2015-05-13 ビオメリューＢｉｏｍｅｒｉｅｕｘ 結腸直腸癌のインビトロ診断のための肝臓脂肪酸結合タンパク質、ｃｅａおよびｃａ１９−９のアッセイのための方法
FR2919063B1 (fr) * 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage du leucocyte elastase inhibitor pour le diagnostic in vitro du cancer colorectal.
CA2694112A1 (en) * 2007-07-20 2009-01-29 The University Of Utah Research Foundation Identification and quantification of biomarkers for evaluating the risk of preterm birth
WO2009046447A1 (en) * 2007-10-06 2009-04-09 Katalin Polgar Fetal open lesion detection system
WO2009076425A2 (en) * 2007-12-13 2009-06-18 3M Innovative Properties Company Methods of analyzing wound samples
WO2009097584A1 (en) * 2008-01-30 2009-08-06 Proteogenix, Inc. Maternal serum biomarkers for detection of pre-eclampsia
WO2009097579A1 (en) * 2008-01-30 2009-08-06 Proteogenix, Inc. Gestational age dependent proteomic changes of human maternal serum for monitoring maternal and fetal health
WO2009123737A2 (en) 2008-04-03 2009-10-08 Becton, Dickinson And Company Advanced detection of sepsis
US8481273B2 (en) * 2008-06-20 2013-07-09 University Of Delaware Perlecan fragments as biomarkers of bone stromal lysis
US20110247404A1 (en) * 2008-06-25 2011-10-13 University Of Utah Research Foundation Identifying and quantifying biomarkers associated with preeclampsia
FR2933773B1 (fr) 2008-07-10 2013-02-15 Biomerieux Sa Procede de dosage de la proteine disulfide isomerase pour le diagnostic in vitro du cancer colorectal
US8476008B2 (en) 2008-07-23 2013-07-02 Diabetomics, Llc Methods for detecting pre-diabetes and diabetes
WO2011053832A1 (en) * 2009-10-29 2011-05-05 The Trustees Of Columbia University In The City Of New York Use of urinary ngal to diagnose sepsis in very low birth weight infants
AU2010325147B2 (en) 2009-11-25 2016-06-30 Hologic, Inc. Detection of intraamniotic infection
EP2545376A4 (en) 2010-03-11 2013-08-28 Univ Louisville Res Found PROCESS FOR PREDICTING AND REDUCING THE RISK OF PREGNANCY LOSSES
JP2013529907A (ja) 2010-05-24 2013-07-25 ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク Ｎｇａｌタンパク質変異体及びその使用
CN103118698A (zh) * 2010-05-28 2013-05-22 意识-Nrg公司 神经调节素同种型，神经调节素多肽和其使用
GB201016161D0 (en) 2010-09-24 2010-11-10 Hansa Medical Ab Diagnostic method
EP2649454B1 (en) * 2010-12-06 2018-06-20 Mycartis N.V. Biomarkers and parameters for hypertensive disorders of pregnancy
GB201102108D0 (en) * 2011-02-07 2011-03-23 Hansa Medical Ab Diagnostic method
WO2013016510A1 (en) * 2011-07-27 2013-01-31 Baylor College Of Medicine Process for preparing biological samples
EP2751126B1 (en) 2011-08-29 2018-03-07 The Regents of The University of California Use of hdl-related molecules to treat and prevent proinflammatory conditions
KR101142434B1 (ko) * 2011-09-08 2012-05-08 (주)오비메드 조기양막파수 산모에서 비침습적인 양수 내 염증 및 감염의 예측 또는 진단 방법
CN102426243B (zh) * 2011-11-17 2014-03-19 成都创宜生物科技有限公司 以补体因子d为检测指标的子痫前期检测试剂盒的制备方法
TW201425332A (zh) 2012-08-03 2014-07-01 Revo Biolog Inc 抗凝血酶用於體外膜氧合之用途
EP3382391A1 (en) 2012-10-24 2018-10-03 NYU Winthrop Hospital Non-invasive biomarker to identify subjects at risk of preterm delivery
EP2925337B1 (en) 2012-11-21 2019-07-03 The Trustees of Columbia University in the City of New York Mutant ngal proteins and uses thereof
WO2014095951A1 (en) * 2012-12-20 2014-06-26 Roche Diagnostics Gmbh Characterization of thermostable dna polymerase
GB201305317D0 (en) * 2013-03-22 2013-05-08 Iles Raymond K Prenatal screening for fetal abnormalities and disorders of pregnancy
US10126305B2 (en) * 2013-06-25 2018-11-13 University of Pittsburg—Of the Commonwealth System of Higher Education Proteomic biomarkers of sepsis in elderly patients
FR3036188B1 (fr) 2015-05-12 2019-06-07 Biomerieux Prediction du risque de developper, pour des patients admis en service de reanimation, une infection disseminee
PL3311158T3 (pl) * 2015-06-19 2023-11-27 Sera Prognostics, Inc. Pary biomarkerów do przewidywania przedwczesnego porodu
MA45272A (fr) 2015-06-27 2018-05-02 Stimlabs Llc Produits issus de liquide amniotique et procédés d'utilisation
CN105372414B (zh) * 2015-10-09 2017-12-22 成都大熊猫繁育研究基地 大熊猫乳汁中关键因子的分析方法
US11693006B2 (en) 2016-12-20 2023-07-04 Sangui Bio Pty. Ltd Blood profiling with protease inhibitors
EP4530633A2 (en) 2017-08-18 2025-04-02 Sera Prognostics, Inc. Pregnancy clock proteins for predicting due date and time to birth
AU2018331400A1 (en) 2017-09-13 2020-04-02 Progenity, Inc. Preeclampsia biomarkers and related systems and methods
US20190224277A1 (en) * 2018-01-22 2019-07-25 CyPhi LLC Bio-mimetic formulation
EP4070113A4 (en) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. ASSESSMENT OF PREECAMPSIA USING FREE AND DISSOCIATE PLACENTAL GROWTH FACTOR ASSAYS
CN113092771A (zh) * 2019-12-23 2021-07-09 首都医科大学附属北京世纪坛医院 尿液α-1B-糖蛋白及其多肽片段在过敏性疾病中的应用
CN113092773A (zh) * 2019-12-23 2021-07-09 首都医科大学附属北京世纪坛医院 尿液α-胰蛋白酶抑制剂重链H4及其多肽片段在过敏性疾病中的应用
CN111951969A (zh) * 2020-08-05 2020-11-17 中翰盛泰生物技术股份有限公司 Hbp在高危妊娠预测中的应用

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5871937A (en) * 1985-04-30 1999-02-16 The Scripps Research Institute Acute phase protein modulating endotoxic activity of lipopolysaccharides, assay methods and polypeptides
US5516702A (en) * 1991-11-06 1996-05-14 Adeza Biomedical Corporation Screening method for identifying women at increased risk for imminent delivery
US6036955A (en) * 1992-03-05 2000-03-14 The Scripps Research Institute Kits and methods for the specific coagulation of vasculature
US5891618A (en) * 1994-01-24 1999-04-06 Xoma Corporation Method for quantifying LBP in body fluids
US5484705A (en) * 1994-01-24 1996-01-16 Xoma Corporation Method for quantifying lipopolysaccharide binding protein
US5932536A (en) * 1994-06-14 1999-08-03 The Rockefeller University Compositions for neutralization of lipopolysaccharides
WO1996037777A1 (en) * 1995-05-23 1996-11-28 Nelson Randall W Mass spectrometric immunoassay
US20020164818A1 (en) * 1995-05-23 2002-11-07 Gruber Karl F. Mass spectrometric immunoassay analysis of specific proteins and variants present in various biological fluids
WO1999043851A1 (en) * 1998-02-25 1999-09-02 National University Of Ireland, Cork Hla linked pre-eclampsia and miscarriage susceptibility gene
US6324479B1 (en) * 1998-05-08 2001-11-27 Rosetta Impharmatics, Inc. Methods of determining protein activity levels using gene expression profiles
US6406921B1 (en) 1998-07-14 2002-06-18 Zyomyx, Incorporated Protein arrays for high-throughput screening
HK1039373A1 (en) * 1998-12-28 2002-04-19 Kabushiki Kaisya Advance System for identifying microorganisms
AU3712200A (en) * 1999-03-01 2000-09-21 Board Of Trustees Of The Leland Stanford Junior University Rapid assay for chorioamnionitis
WO2000060354A1 (en) * 1999-04-07 2000-10-12 Unilever Plc Lipopolysaccharide immunoassay and test device
AU6615500A (en) * 1999-07-28 2001-02-19 Genetics Institute Inc. Preventing immune-mediated abortion by inhibiting costimulation
US6653151B2 (en) * 1999-07-30 2003-11-25 Large Scale Proteomics Corporation Dry deposition of materials for microarrays using matrix displacement
US6703202B2 (en) * 1999-11-30 2004-03-09 Oxo Chemie Ag Evaluating and predicting clinical outcomes by gene expression analysis
EP1481249A1 (en) * 2002-03-07 2004-12-01 Cambridge University Technical Services Limited Scd fingerprints
CN1395103A (zh) * 2002-07-31 2003-02-05 中华人民共和国北京出入境检验检疫局 疯牛病病原检测压电生物芯片及其制备方法
US20060127962A1 (en) * 2002-11-14 2006-06-15 Ciphergen Biosystems, Inc. Biomarkers for intro-amniotic inflammation
US20060240495A1 (en) * 2003-02-05 2006-10-26 Ciphergen Biosystems, Inc. Non-invasive assessment of intra-amniotic environment
US7191068B2 (en) * 2003-03-25 2007-03-13 Proteogenix, Inc. Proteomic analysis of biological fluids
WO2005017192A2 (en) * 2003-08-14 2005-02-24 The General Hospital Corporation Screening for gestational disorders
JP4568282B2 (ja) * 2003-09-23 2010-10-27 ザ ジェネラル ホスピタル コーポレイション 妊娠性疾患のスクリーニング
US20060063162A1 (en) * 2004-09-23 2006-03-23 Deng David X Biological marker for inflammation
US20060078998A1 (en) * 2004-09-28 2006-04-13 Singulex, Inc. System and methods for sample analysis
GB0426982D0 (en) * 2004-12-09 2005-01-12 Secr Defence Early detection of sepsis
EP1869463A4 (en) * 2005-04-15 2010-05-05 Becton Dickinson Co SEPSIS DIAGNOSIS
WO2007021860A2 (en) * 2005-08-11 2007-02-22 Bayer Healthcare Llc QUANTITATIVE ASSAYS FOR PDGFR-β IN BODY FLUIDS
AU2006299417A1 (en) * 2005-10-03 2007-04-12 Biosite Incorporated Methods and compositions for diagnosis and/or prognosis in Systemic Inflammatory Response Syndromes
WO2007047041A2 (en) * 2005-10-14 2007-04-26 Hyperion Biotechnology, Inc. Methods and compositions for biomarkers associated with change in physical performance
US7790463B2 (en) * 2006-02-02 2010-09-07 Yale University Methods of determining whether a pregnant woman is at risk of developing preeclampsia
US20080031874A1 (en) * 2006-02-06 2008-02-07 Sanders Martin E Treatment of endotoxemia using endotoxin neutralizing agents
EP2021373A4 (en) * 2006-05-31 2010-06-02 Hanwa Chemical Corp MONOCLONAL ANTIBODY VCAM-1 SPECIFIC
US20080199426A1 (en) * 2007-01-11 2008-08-21 Sukhatme Vikas P Methods and compositions for the treatment and diagnosis of vascular inflammatory disorders or endothelial cell disorders

Also Published As

Publication number Publication date
US20080299594A1 (en) 2008-12-04
CN1795387A (zh) 2006-06-28
EP1618388B1 (en) 2009-02-18
JP2006524331A (ja) 2006-10-26
DK1618388T3 (da) 2009-05-18
AU2004225527A1 (en) 2004-10-14
WO2004088324A3 (en) 2005-06-02
JP2010122238A (ja) 2010-06-03
US20090055099A1 (en) 2009-02-26
US7191068B2 (en) 2007-03-13
JP5011410B2 (ja) 2012-08-29
ATE423322T1 (de) 2009-03-15
EP1618388A2 (en) 2006-01-25
US20040197930A1 (en) 2004-10-07
ES2322593T3 (es) 2009-06-23
WO2004088324A2 (en) 2004-10-14
DE602004019511D1 (de) 2009-04-02
EP2088433A1 (en) 2009-08-12
CA2560972A1 (en) 2004-10-14
AU2010200352A1 (en) 2010-02-18
AU2004225527B2 (en) 2009-10-29

Similar Documents

Publication Publication Date Title
MXPA05010325A (es) Analisis proteomico de fluidos biologicos.
MX2009004774A (es) Analisis proteomico de fluidos cervicouterinovaginales para detectar infeccion intrauterina o para determinar el riesgo de parto prematuro en una embarazada.
IL152650A0 (en) Microfluidic channel embryo and/or oocyte handling, analysis and biological evaluation
GB2423151B (en) Examination systems for biological samples
WO2004007743A3 (en) Use of cpg nucleic acids in prion-disease
AU3541401A (en) Methods and kits for identifying elite event gat-zm1 in biological samples
WO2002010725A3 (en) Method for non-invasively determining the concentration of an analyte by compensating for the effect of tissue hydration
AU2002230650A1 (en) Method for diagnosing pathology in biological samples
WO2004062475A3 (en) Fluorescent assays for protein kinases
WO2007023444A3 (en) A method for evaluation of a gemstone
ATE424560T1 (de) Marker für neuromyelitis optica
WO2002095396A3 (en) In line test device and methods of use
IL173843A0 (en) Assay for coronaviruses, reagents for use therein and kits containing the same
WO2004055491A3 (en) Novel method for sequence determination using nmr
DE50207866D1 (de) Verwendung löslicher cytokeratin-1-fragmente in diagnostik
WO2005056585A3 (en) Sars coronavirus s proteins and uses thereof
DE50101193D1 (de) Zugangskanüle für endoskopische Operationen, insbesondere für die Arthroskopie
WO2003084384A3 (en) Diagnosis of flavivirus infection
WO2005054516A3 (en) Peptide nucleic acid probes for analysis of certain staphylococcus species
WO2004113574A3 (en) Methods for disease screening
IL159479A0 (en) Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis
TW200508936A (en) The establishment of proteome structure profile databases and their uses
FI990380A7 (fi) Diagnostinen ja seulontamenetelmä
TW200716978A (en) Method
AU2001263793A1 (en) Kit, method and microarray for determining the sex of a human foetus

Legal Events

Date Code Title Description
FG Grant or registration
GB Transfer or rights